Inspire Medical Systems (INSP) Tops Q2 Earnings Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to loss of $0.41 per share a year ago.
Inspire Medical (INSP) Gets FDA Nod for Inspire V System
Inspire Medical (INSP) secures FDA approval for its advanced Inspire V therapy system, featuring an innovative neurostimulator and Bluetooth technology for enhanced patient and physician control.
Wall Street's Insights Into Key Metrics Ahead of Inspire (INSP) Q2 Earnings
Besides Wall Street's top -and-bottom-line estimates for Inspire (INSP), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
Sleep Apnea Device Marker Inspire's Stock Rises on Improved Outlook
Inspire Medical Systems (INSP) shares rose Monday after the maker of an implanted device to treat sleep apnea released preliminary results and updated guidance that beat forecasts.
Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
Inspire Medical's (INSP) receipt of the latest CE mark certification will likely enable it to continue to deliver Inspire products globally.
Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028
The recall of Inspire Medical 's (INSP) Inspire IV Implantable Pulse Generators might dampen the company's future sales.
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
The FDA has labeled a recall of Inspire Medical Systems, Inc.'s INSP nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind.
Why Is Inspire (INSP) Down 7.3% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
